reports
Thales: 1 director
A director at Thales bought 500 shares at 239.100EUR and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...
Press Release: Sanofi’s Sarclisa approved in the EU for the treatment ...
Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction treatment significantly improved MRD negativity benefit and prolonged PFS compared to VRd aloneWith the first global approval in TE NDMM, Sarclisa is now approved in the EU across all lines of therapy, regardless of transplant eligibility Paris, July 25, 2025. Foll...
Communiqué de presse : Sarclisa de Sanofi approuvé dans l’UE pour le t...
Communiqué de presse : Sarclisa de Sanofi approuvé dans l’UE pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe Sarclisa de Sanofi approuvé dans l’UE pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe Approbation fondée sur l’étude de phase 3 GMMG-HD7, qui a montré que l’ajout de Sarclisa au traitement d’induction VRd améliorait significativement le taux de négativité de la MRD (maladie résiduelle minimale) et prolongeait la SSP (survie sans progression) par rapport au VRd seulA...
- Olfa Taamallah
- Yan Derocles
- Olfa Taamallah
- Yan Derocles
- Carole Braudeau
Credit Morning 07/23/2025
Auchan: First-half sales are expected to fall by 3.3% in France (Olivier Dauvers)|Retail sales in France fell sharply in June, hit by the heatwave and one less Saturday.|ams OSRAM: € 500m private placement of new 2029 notes, preliminary Q2 figures in line|Unicredit withdraws its bid for Banco BPM and publishes strong Q2 results|
- Olfa Taamallah
- Yan Derocles
EQNR EQUINOR ASA
RNO RENAULT SA
KPN ROYAL KPN NV
TKA TELEKOM AUSTRIA AG
HO THALES SA
LONN LONZA GROUP AG
GLE SOCIETE GENERALE S.A. CLASS A
RAND RANDSTAD NV
ALO ALSTOM SA
ASM ASM INTERNATIONAL N.V.
GAS NATURGY ENERGY GROUP S.A.
FCC FOMENTO DE CONSTRUCCIONES Y CONTRATAS S.A.
UCG UNICREDIT S.P.A.
IBE IBERDROLA SA
BRD BRD-GROUPE SOCIETE GENERALE
TLV BANCA TRANSILVANIA S.A.
VACN VAT GROUP AG
SAP SAP SE
BG BAWAG GROUP AG
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
AM DASSAULT AVIATION
STMN STRAUMANN HOLDING AG
- Carole Braudeau
Morning Crédit 23/07/2025
Auchan : le chiffre d’affaires reculerait de -3,3% en France au S1 (Olivier Dauvers)|Forte baisse des ventes retail en France en juin, pénalisées par la canicule et un samedi de moins|ams OSRAM : placement privé de 500 m EUR d’obligations 2029, chiffres préliminaires au T2 en ligne|Unicredit renonce à son offre sur Banco BPM et publie de solides résultats T2|
- Olfa Taamallah
- Yan Derocles
EQNR EQUINOR ASA
RNO RENAULT SA
KPN ROYAL KPN NV
TKA TELEKOM AUSTRIA AG
HO THALES SA
LONN LONZA GROUP AG
GLE SOCIETE GENERALE S.A. CLASS A
RAND RANDSTAD NV
ALO ALSTOM SA
ASM ASM INTERNATIONAL N.V.
GAS NATURGY ENERGY GROUP S.A.
FCC FOMENTO DE CONSTRUCCIONES Y CONTRATAS S.A.
UCG UNICREDIT S.P.A.
IBE IBERDROLA SA
BRD BRD-GROUPE SOCIETE GENERALE
TLV BANCA TRANSILVANIA S.A.
VACN VAT GROUP AG
SAP SAP SE
BG BAWAG GROUP AG
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
AM DASSAULT AVIATION
STMN STRAUMANN HOLDING AG
- Anthony Dick
- Michael Foundoukidis
- Anthony Dick
- Michael Foundoukidis
- Olfa Taamallah
- Yan Derocles
- Olfa Taamallah
- Yan Derocles
Renault Group 2025 H1 sales results: Renault Group brands stay the cou...
Renault Group 2025 H1 sales results: Renault Group brands stay the course in a challenging environment PRESS RELEASEJuly 23, 2025 RENAULT GROUP BRANDS STAY THE COURSE IN A CHALLENGING ENVIRONMENT Renault Group recorded an increase in its overall sales in the first half of 2025 (+1.3% vs 2024), reaching 1,169,773 vehicles sold.Internationally1, the Renault brand grew by 16.3% with the commercial success of the first models of the International Game Plan.In Europe2, in a passenger car (PC) market down by 1.0%, the Group grew by 5.4% and reached 708,106 registered vehicles. Sandero and Clio a...
Résultats commerciaux S1 2025 : Les marques de Renault Group tiennent ...
Résultats commerciaux S1 2025 : Les marques de Renault Group tiennent le cap dans un contexte exigeant COMMUNIQUÉ DE PRESSE23 juillet 2025 LES MARQUES DE RENAULT GROUP TIENNENT LE CAP DANS UN CONTEXTE EXIGEANT Renault Group enregistre au premier semestre 2025 une hausse de ses ventes globales (+1,3 % vs 2024) pour atteindre 1 169 773 véhicules vendus. A l’international1, la marque Renault croît de 16,3 % avec le succès commercial des premiers modèles de l’International Game Plan.En Europe2, dans un marché des véhicules particuliers (VP) en baisse de 1,0 %, le Groupe progresse de 5,4...
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccin...
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline Paris, July 22, 2025. Sanofi today announces it has entered into an agreement to acquire Vicebio Ltd (“Vicebio”), a privately held biotechnology company headquartered in London, UK. The acquisition brings an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), both respiratory viruses, and expands the capabilities in vaccine design and development with Vicebio’s ‘Molecular Clamp’ tec...
Communiqué de presse : Sanofi va acquérir Vicebio et enrichir son pipe...
Communiqué de presse : Sanofi va acquérir Vicebio et enrichir son pipeline de vaccins respiratoires Sanofi va acquérir Vicebio et enrichir son pipeline de vaccins respiratoires Paris, le 22 juillet 2025. Sanofi annonce aujourd'hui la conclusion d'un accord pour l'acquisition de Vicebio Ltd (« Vicebio »), une société de biotechnologie privée dont le siège est à Londres, au Royaume-Uni. Cette acquisition apporte à Sanofi un candidat-vaccin combiné en phase précoce de développement contre le virus respiratoire syncytial (VRS) et le métapneumovirus humain (hMPV), deux virus respiratoires, et r...
Information relating to the total number of voting rights and share ca...
Information relating to the total number of voting rights and share capital - June 30, 2025 Disclosure of the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the French Commercial Code and the Article 223-16 of the Règlement général de l’Autorité des marchés financiers (Regulation of the French stock market authority) Company name of the issuer: Renault S.A. 122 - 122 bis Avenue du Général Leclerc 92100 Boulogne-Billancourt (ISIN code: FR0000131906 – RNO) DateTotal number of issued sharesTotal number of voting rights June 30, 2025295,722,...
Renault SA :Half-year report on the liquidity contract - H1 2025
Renault SA :Half-year report on the liquidity contract - H1 2025 Regulated InformationJuly 21, 2025 HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT Under the liquidity agreement entered into between Renault SA and Exane BNP Paribas, the following resources appeared on the liquidity account on June 30, 2025: 128,850 shares21,129,764 euros In the first half of 2025, were carried out: 9,654 purchase transactions for 2,019,314 shares and 93,437,616 euros12,415 sale transactions for 1,914,067 shares and 89,088,222 euros For information: 1. In the previous half-year report, on December 31, 20...
Information relative au nombre total de droits de vote et de capital -...
Information relative au nombre total de droits de vote et de capital - 30 juin 2025 Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8-II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiers Dénomination sociale de l'émetteur : Renault S.A.122 - 122 bis Avenue du Général Leclerc92100 Boulogne-Billancourt (Code ISIN : FR0000131906 – RNO) DateNombre d’actions composant le capital socialNombre total de droits de vote30 juin 2025295 722 284Nombre de droits de vote théoriques (1) : 403 511 287Nombre ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.